Related references
Note: Only part of the references are listed.Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Fatemeh Heidary et al.
JOURNAL OF ANTIBIOTICS (2020)
Scalable molecular dynamics on CPU and GPU architectures with NAMD
James C. Phillips et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
Daniel W. Kneller et al.
NATURE COMMUNICATIONS (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Indwiani Astuti et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros Rosa et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Computer Aided Drug Design: Success and Limitations
Mohammad Hassan Baig et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic
Pauline J. van der Watt et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Mechanisms of echinocandin antifungal drug resistance
David S. Perlin
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
The importin α/β-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways
Friederike K. Kosyna et al.
BIOLOGICAL CHEMISTRY (2015)
Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity
Danielle Needle et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
Ivan Gentile et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Computational drug discovery
Si-sheng Ou-Yang et al.
ACTA PHARMACOLOGICA SINICA (2012)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
An AlphaScreen®-Based Assay for High-Throughput Screening for Specific Inhibitors of Nuclear Import
Kylie M. Wagstaff et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Uncovering false positives on a virtual screening search for cruzain inhibitors
Alberto Malvezzi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Share Paper
